Skip to content
Seqlense EUR-Lex

2005/171/EC: Commission Decision of 23 February 2005 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2004 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2005) 293) (Text with EEA relevance)

CELEX
32005D0171
Document type
DEC_ENTSCHEID
Sector
Legislation
Date of document
2005-02-23
In force since
2005-02-23
Status
In force

Text

Article-level text, parsed from the formex manifestation.

Article 1

1 The quantity of controlled substances of Group I (chlorofluorocarbons 11, 12, 113, 114 and 115) subject to Regulation (EC) No 2037/2000 which may be used for essential medical uses in the Community in 2004 shall be 1428533,000 ODP (ozone depletion potential) kilograms.

2 The quantity of controlled substances of Group I (chlorofluorocarbons 11, 12, 113, 114 and 115) and Group II (other fully halogenated chlorofluorocarbons) subject to Regulation (EC) No 2037/2000 which may be used for essential laboratory uses in the Community in 2004 shall be 73336,765 ODP kilograms.

3 The quantity of controlled substances of Group III (halons) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory use in the Community in 2004 shall be 19268,700 ODP kilograms.

4 The quantity of controlled substances of Group IV (carbon tetrachloride) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory uses in the Community in 2004 shall be 141834,000 ODP kilograms.

5 The quantity of controlled substances of Group V (1,1,1-trichloroethane) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory uses in the European Union in 2004 shall be 529,300 ODP kilograms.

6 The quantity of controlled substances of Group VII (hydrobromofluorocarbons) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory uses in the Community in 2004 shall be 3,070 ODP kilograms.

7 The quantity of controlled substances of group IX (bromochloromethane) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory uses in the Community in 2004 shall be 13,248 ODP kilograms.

Article 2

The chlorofluorocarbon metered-dose inhalers (CFC-MDIs) listed in Annex I shall not be placed on markets that have determined CFCs for these products to be non-essential.

Article 3

During the period 1 January to 31 December 2004 the following rules shall apply: 1. The allocation of essential medical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 shall be to the companies indicated in Annex II. 2. The allocation of essential laboratory use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 and other fully halogenated chlorofluorocarbons shall be to the companies indicated in Annex III. 3. The allocation of essential laboratory use quotas for halons shall be to the companies indicated in Annex IV. 4. The allocation of essential laboratory use quotas for carbon tetrachloride shall be to the companies indicated in Annex V. 5. The allocation of essential laboratory use quotas for 1,1,1-trichloroethane shall be to the companies indicated in Annex VI. 6. The allocation of essential laboratory use quotas for hydrobromofluorocarbons shall be to the companies indicated in Annex VII. 7. The allocation of essential laboratory use quotas for bromochloromethane shall be to the companies indicated in Annex VIII. 8. The essential use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115, other fully halogenated chlorofluorocarbons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane shall be as set out in Annex IX.

Article 4

Decision 2004/209/EC is repealed. References to the repealed Decision shall be construed as references to this Decision.

Article 5

This Decision is addressed to the following undertakings: 3M Health Care Ltd 3M House Morley Street Loughborough Leicestershire LE11 1EP United Kingdom Aventis London Road, Holmes Chapel Cheshire CW4 8BE United Kingdom Bespak PLC North Lynn Industrial Estate King's Lynn Norfolk PE30 2JJ United Kingdom Boehringer Ingelheim GmbH Binger Strasse 173 D-55216 Ingelheim am Rhein Chiesi Farmaceutici SpA Via Palermo 26/A I-43100 Parma GlaxoSmithKline Speke Boulevard Speke Liverpool L24 9JD United Kingdom IG Sprühtechnik GmbH Im Hemmet 1 D-79664 Wehr Inyx Pharmaceuticals Ltd Astmoor Industrial Estate 9 Arkwright Road Runcorn Cheshire WA7 1NU United Kingdom IVAX Ltd Unit 301 Industrial Park Waterford Ireland Jaba Farmaceutica SA Rua da Tapada Grande, 2 P-2710-089, Abrunheira Sintra Laboratorio Aldo Union SA Baronesa de Maldá 73 Espluges de Llobregat E-08950 Barcelona Otsuka Pharmaceuticals (E) Provenca, 388 E-08025 Barcelona SICOR SpA Via Terrazzano 77 I-20017 RHO Milano Schering-Plough Labo NV Industriepark 30 B-2220 Heist Op Den Berg Valvole Aerosol Research Italiana (VARI) Spa — LINDAL Group Italia Via del Pino, 10 Olginate (LC) I-23854 Italia Valeas SpA Pharmaceuticals Via Vallisneri, 10 I-20133 Milano Valois SA 50 avenue de l’Europe F-78160 Marly-Le-Roi Acros Organics bvba Janssen Pharmaceuticalaan 3a B-2440 Geel Airbus France 316, route de Bayonne F-31300 Toulouse Agfa-Gevaert NV Septestraat 27 B-2640 Mortsel Bie & Berntsen Sandbækvej 7 DK-2610 Rødovre Biosolove BV Waalreseweg 17 5554 HA Valkenswaard The Netherlands Butterworth Laboratories Ltd 54 Waldegrave Road, Teddington Middlesex TW11 8NY United Kingdom Carl Roth GmbH Schoemperlenstr. 1—5 D-76185 Karlsruhe Elcom Group Okružní 988 CZ-735 14 Orlová — Lutyně Environnement SA 111, Bld Robespierre BP 4513 F-78304 Poissy Fisher Scientific Bishop Meadow Road Loughborough LE11 5RG United Kingdom Health Protection Inspectorate-Laboratories Paldiski mnt 81 EE-10617 Tallinn Honeywell Specialty Chemicals Wunstorfer Straße 40 Postfach 100262 D-30918 Seelze Institut scientifique de service public (ISSeP) Rue du Chéra 200 B-4000 Liège Institut E. Malvoz (B) Quai du Barbou, 4 B-4000 Liège Ineos Fluor Ltd PO Box 13, The Heath Runcorn Cheshire WA7 4QF United Kingdom Katholieke Universiteit Leuven Krakenstraat 3 B-3000 Leuven Laboratoires sérobiologiques 3, rue de Seichamps F-54425 Pulnoy LGC Promochem GmbH Mercatorstr. 51 D-46485 Wesel Mallinckrodt Baker BV Teugseweg 20 7418 AM Deventer The Netherlands Merck KgaA Frankfurter Strasse 250 D-64271 Darmstadt Mikro+Polo d.o.o. Lackova 78 SLO-2000 Maribor Panreac Química SA Riera de Sant Cugat 1 E-08110 Montcada I Reixac (Barcelona) Rohs Chemie GmbH Berliner Str. 54 D-53819 Neunkirchen-Seelsheid Sanolabor d.d. Leskoškova 4 SLO-Ljubljana SDS Solvants, Documentation, Synthèses SA Z.I. de Valdonne, BP 4 F-13124 Peypin Sigma Aldrich Chemie GmbH Riedstrasse 2 D-89555 Steinheim Sigma Aldrich Chimie SARL 80 rue de Luzais L'Isle-d'Abeau Chesnes F-38297 St-Quentin-Fallavier Sigma Aldrich Company Ltd The Old Brickyard New Road Gillingham SP8 4XT United Kingdom Sigma Aldrich Laborchemikalien Wunstorfer Straße 40, Postfach 100262 D-30918 Seelze VWR I.S.A.S. 201, rue Carnot F-94126 Fontenay-sous-bois University Of Technology Vienna Institut of Industrial Electronics and Material Science Gusshausstrasse 27-29 A-1040 Wien YA-Kemia Oy — Sigma-Aldrich Finland Teerisuonkuja 4 FI-00700 Helsinki

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions